GlassScriptPhysician profile
Michael Eric Lipkin
NPI 1710173869
$293,192.44
in general payments reported to CMS, 2019-2025
17 companies · $59K in 2025
The $59K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $28K · 2021: $15K · 2022: $43K · 2023: $33K · 2024: $23K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Travel and Lodging: $5,049 · Food and Beverage: $2,835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,867.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,500.00 |
| Travel and Lodging | $5,048.51 |
| Food and Beverage | $2,835.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $117,722.94 | 2019-2025 | Moses, General - Kidney Stone Disease, Moses 550 Dfl |
| Ethicon INC. | $67,681.73 | 2019-2020 | |
| Olympus America INC. | $37,441.92 | 2022-2025 | Soltive, Uretero-Reno Fiberscope, Soltive |
| Karl Storz Endoscopy-America | $25,083.20 | 2019-2024 | Flex-X, Scopesafelaser Fiber, Hopkins |
| Novo Nordisk INC | $8,693.29 | 2022-2025 | Rivfloza |
| Lumenis, INC | $8,588.04 | 2020 | |
| Alnylam Pharmaceuticals INC. | $8,355.00 | 2020-2022 | |
| Becton, Dickinson and Company | $6,037.50 | 2025 | |
| Cook Incorporated | $4,875.00 | 2021-2023 | S~Curve |
| Olympus Corporation of The Americas | $4,380.00 | 2025 | Soltive |
| C. R. Bard, INC. & Subsidiaries | $1,855.91 | 2021-2024 | |
| Ambu INC. | $1,514.17 | 2021-2025 | |
| Calyxo, INC. | $643.29 | 2024-2025 | Cvac Aspiration System |
| Richard Wolf Medical Instruments Corp. | $145.85 | 2019 | |
| Cook Medical LLC | $121.50 | 2022-2025 | Litho 150 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $34.80 | 2019 | |
| Novo Nordisk Health Care Ag | $18.30 | 2025 | Rivfloza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lipkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.